Needham & Company
-
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
-
Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference
-
Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference
-
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates
-
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates
-
Needham & Company Reiterates Buy Rating, $31 Price Target on Shattuck Labs (STTK)
-
Shattuck Labs Announces Participation in Upcoming 21st Annual Needham Virtual Healthcare Conference
-
Shattuck Labs Announces Participation in Upcoming 21st Annual Needham Virtual Healthcare Conference
-
Shattuck Labs (STTK) PT Lowered to $31 at Needham & Company
-
Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
-
Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
-
Shattuck Labs (STTK) PT Lowered to $46 at Needham & Company
-
Shattuck Labs Announces Participation in Needham’s 20th Annual Healthcare Conference
-
Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
-
Shattuck Labs Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Shattuck Labs Inc. (STTK) IPO Opens 30% Higher
-
Shattuck Labs Inc. (STTK) Prices 11.882M Share Upsized IPO at $17/Sh
-
Shattuck Labs Announces Pricing of Upsized Initial Public Offering

